Denver Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Denver Investment Advisors's BMY Position: Q1 2018 in Review
Denver Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2018, selling an estimated $123K and leaving 75,029 shares worth $4.75M. The position accounts for 0.25% of the portfolio, ranked #113.
Denver Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 20 quarters since. The position peaked at $17.7M in Q1 2014. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.
- Denver Investment Advisors held 75,029 shares of Bristol-Myers Squibb worth $4.75M as of Q1 2018.
- Denver Investment Advisors sold 1,911 Bristol-Myers Squibb shares in Q1 2018, an estimated $123K.
- Bristol-Myers Squibb made up 0.25% of Denver Investment Advisors's portfolio in Q1 2018, its #113 holding.
- Denver Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 20 quarters since.
- Denver Investment Advisors's Bristol-Myers Squibb position peaked at $17.7M in Q1 2014.
- 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.
Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.